Clinical Trial

Intensity-Modulated Stereotactic Radiation Therapy in Treating Patients With Grade II-IV Glioma

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This phase II trial studies how well intensity-modulated stereotactic radiation therapy works in treating patients with grade II-IV glioma. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2017-08-14; most recent amendment 2026-01-23.
Status change: Recruiting → Active, Not Recruiting 2026-01-23
Status change: Active, Not Recruiting → Recruiting 2018-06-11
Status change: Recruiting → Active, Not Recruiting 2018-03-26
Trial Details
NCT Number NCT03251027
Lead Sponsor Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Conditions Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma
Enrollment 100 participants
Start Date 2017-07-17
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-27